|
Immunicum is featured in BiotechSweden. Read the article here. |
|
|
Immunicum enrolls the first patient in its COMBIG clinical phase I/II-trial in renal cell carcinoma.
Read the news in BiotechSweden here, in NyTeknik here, or in GöteborgBio here. |
|
Immunicum closes its first in a series of planned financing rounds throughout 2012. |
|
Immunicum's vaccine cells (intended for clinical use) are approved and released by the assigned Qualified Person (QP). |
|
|
|
|
|